Why Intel Hired the Former CEO of Micron's Big Rival SK Hynix
Intel stock has risen sharply on excitement over its chip-manufacturing plans and a new hire could provide a further boost.
----
Charles Schwab Breaks Into the Prediction Market Business
The brokerage is working with Cboe to offer yes-or-no contracts tied to the performance of the S&P 500 index.
----
ASML Shares Slip on Report of U.S. Concern That China Has Its Tech
The Trump administration expressed concern that one of the Dutch company's high-end lithography machines was being used in China-despite export restrictions.
----
Google Is Using Nvidia's Playbook to Build a Rival AI Chip Business
Wielding its war chest to win data-center customers for its silicon, the world's second-biggest company is taking a page from No. 1.
----
Why Apple's War Chest Can't Win the Memory War
The iPhone maker's clout as a buyer has taken a major hit from the AI boom.
----
UniCredit to Lift Commerzbank Stake to 42.5% After Initial Offer Period
The Italian lender plans to reopen its offer to Commerzbank shareholders for another two weeks.
----
Reliance's Jio Platforms to Seek India Listing
Jio Platforms will file for an initial public offering in India, according to parent company Reliance Industries Chairman Mukesh Ambani.
----
Chinese Autonomous-Driving Unicorn Targets $1 Billion Hong Kong IPO
Momenta's valuation has reached around $9 billion as it gears up to list in Hong Kong, people familiar with the matter said.
----
SpaceX's Strength in Space, Connectivity Supports Initial Credit Ratings, Firms Say
S&P Global Ratings, Moody's Ratings and Fitch Ratings also noted risks tied to the company's capital needs and nascent AI business, and gave it a stable outlook.
----
Amazon's New Weapon: Selling Custom AI Chips to Take On Nvidia
Amazon Web Services, the company's cloud-computing arm, has opened discussions with potential customers looking to use its custom Trainium chips.
----
FDA Votes in Favor of Benefit-Risk Profile for Moderna's Flu Vaccine
Moderna said an advisory committee voted unanimously that the benefits of the vaccine, mRNA-1010, exceed the risks for the prevention of flu in adults 50 through 64 years old, and in adults 65 and older.
----
These Are the Country's Top CEOs. They've Maximized the Moment, Whether in Pizza, Sports, or Tech.
From Delta's Bastian to Exxon Mobil's Woods, these 25 leaders have positioned their companies for long-term success.
----
Air Force Buys New Generation of Drones Made to Strike Deep Into Enemy Territory
Despite cheap drones having success in Ukraine, the military said the expensive new aircraft were necessary for wars of the future.
(END) Dow Jones Newswires
June 19, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.